Transcriptomics

Dataset Information

47

TCA1 Stimulon in Mycobacterium tuberculosis


ABSTRACT: A cell-based phenotypic screen for inhibitors of biofilm formation in Mycobacterium tuberculosis (Mtb) identified the small molecule TCA1, which has bactericidal activity against both drug susceptible and drug resistant Mtb, and synergizes with rifampicin (RIF) or isoniazid (INH) in sterilization of Mtb in vitro. In addition, TCA1 has bactericidal activity against non-replicating Mtb in vitro and is efficacious in acute and chronic Mtb infection mouse models, both alone and in combination with INH or RIF. Transcriptional analysis revealed that TCA1 down-regulates genes known to be involved in Mtb dormancy and drug tolerance. Mutagenesis and affinity-based methods identified DprE1 and MoeW, enzymes involved in cell wall and molybdenum cofactor biosynthesis, respectively, as the targets responsible for TCA1’s activity. These in vitro and in vivo results indicate that TCA1functions by a novel mechanism and suggest that it may be the first product of a promising new approach for the development of anti-tuberculosis drugs. Overall design: Transcriptional profile of TCA1-treated cells relative to DMSO-treated control. Three biological replicates, third is a dye flip.

INSTRUMENT(S): JCVI PFGRC Mycobacterium tuberculosis 22K v4 array designed primarily based on strain H37Rv

ORGANISM(S): Mycobacterium tuberculosis H37Rv  

SUBMITTER: Brian Weinrick 

PROVIDER: GSE42151 | GEO |

SECONDARY ACCESSION(S): PRJNA179515

REPOSITORIES: GEO

Similar Datasets

2013-05-24 | E-GEOD-42151 | ArrayExpress
1000-01-01 | S-EPMC4948005 | BioStudies
2018-01-01 | S-EPMC6056394 | BioStudies
2020-01-01 | S-EPMC7281663 | BioStudies
2013-01-01 | S-EPMC6807317 | BioStudies
2018-01-01 | S-EPMC5919409 | BioStudies
2018-01-01 | S-EPMC6202043 | BioStudies
2020-01-01 | S-EPMC7533241 | BioStudies
2020-01-01 | S-EPMC7442848 | BioStudies
2019-01-01 | S-EPMC6858147 | BioStudies